Stay updated on Amgen Press Releases
Sign up to get notified when there's something new on the Amgen Press Releases page.
Latest updates to the Amgen Press Releases page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedAmgen has made significant updates, including the FDA approval of IMDELLTRA™ for extensive-stage small cell lung cancer and the launch of OTEZLA® for pediatric plaque psoriasis, while several upcoming presentations and financial results have been removed from the site.SummaryDifference100%
- Check25 days agoChange DetectedAmgen has presented new data for its first-in-class treatment, Imdelltra™ (Tarlatamab-DLLE), for small cell lung cancer at WCLC 2024.SummaryDifference29%
- Check32 days agoChange DetectedAmgen has announced several significant updates, including the availability of Otezla® for pediatric plaque psoriasis, upcoming presentations at major healthcare conferences, and the approval of Blincyto® for a specific type of leukemia.SummaryDifference100%
- Check46 days agoChange DetectedAmgen has made several significant announcements, including the approval of Blincyto® for B-ALL and the first quarter 2024 financial results, while notable deletions include the second quarter 2024 financial results and the announcement of the third quarter dividend.SummaryDifference100%
- Check60 days agoChange DetectedAmgen has reported its second quarter 2024 financial results and announced a third quarter dividend, along with a webcast for the financial results.SummaryDifference38%
- Check67 days agoChange DetectedIn June 2024, the FDA approved Blincyto® for treating CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia, while Amgen announced positive Phase 3 trial results for Uplizna® and plans to present at several major healthcare conferences.SummaryDifference100%
Stay in the know with updates to Amgen Press Releases
Enter your email address, and we'll notify you when there's something new on the Amgen Press Releases page.